Interní Med. 2005; 7(6): 288-290

Adverse effect of amiodaron

MUDr. Yvona Hrčková2, MUDr. Hana Šarapatková1, prof. MUDr. Jan Lukl CSc2
1 Interní a endokrinologická ordinace Olomouc
2 I. interní klinika FN a LF UP Olomouc

Amiodaron is a very effective drug and it is widely used for many therapeutic indications in cardilology. At the same time it is a drug with many adverse effects. It’s very important to be mindful of all potential risks in treatment. The authors prezent an overview of all adverse effects, the most important contraindications and interactions of amiodaron.

Keywords: Key words: amiodaron, adverse effects, contraindications, interactions.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrčková Y, Šarapatková H, Lukl J. Adverse effect of amiodaron. Interní Med. 2005;7(6):288-290.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amiodarone trials meta-analysis investigators effect of prophylactic amiodarone on mortality after myocardial infarction and congestive hearth failure: Meta analysis of individual data from 6, 500 p. on rand. trials. Lancet, 1997; 350: 1417-1424.
    2. Ascherman M. Kardiologie. Galen, 2004: 154.
    3. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine, 5th Edition: 1997: 932-939.
    4. Bytešník J. Léčba arytmií amiodaronem ve světle nových poznatků. Cor Vasa 2000; 42/2/: 193-199.
    5. Crawford MH, DiMarco J. Cardiology, 2001: Mosly. 4.2.11-13, 4.15.6, 4.2.12 Go to original source... Go to PubMed...
    6. Lukl J, a kol. Srdeční arytmie. Grada, 1996.
    7. Lukl J, a kol. Pokroky v arytmologii. Grada, 1997.
    8. Lukl J, a kol. Moderní léčba arytmií. Grada, 2001.
    9. Lukl J. Klinická kardiologie stručně, Olomouc, 2004.
    10. Jiravská Godula B, a kol. Nežádoucí účinky amiodaronu, Klin. farmakologie a Farmacie, 2004; 18: 171-174.
    11. Jirsa J: Thyreopatie po amiodaronu, Kapi Kardio 2003, 5, 110-114.
    12. Stárka L, a kol. Aktuální endokrinologie, Maxdorf, 1999: 415-424. Zamrazil V, Němec J: Vliv amiodaronu na štítnou žlázu.
    13. Štejfa M. Kardiologie, Grada, 1998: 214-216.
    14. Vítovec J, Špinar J. Farmakoterapie kardiovaskulárních onemocnění.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.